- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Plasma Concentration of ASP1941 in United Kingdom
Total 215 results
-
AstraZenecaCompletedPharmacokinetic Profile | Plasma ConcentrationUnited Kingdom
-
University of VirginiaThe University of QueenslandCompletedPlasma Concentration of AntibioticsUnited States
-
Newcastle UniversityUnknownChange in Fasting Plasma LDL-cholesterol Concentration After the Consumption of QuinoaUnited Kingdom
-
PepsiCo Global R&DCompletedPlasma Caffeine ConcentrationUnited States
-
AcelRx Pharmaceuticals, Inc.Completed
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of ASP1941United States
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of ASP1941United States
-
Astellas Pharma Global Development, Inc.CompletedHealthy Volunteers | Pharmacokinetics of ASP1941United States
-
King's College LondonCompletedHealthy Men | Raised Fasting Plasma Triacylglycerol ConcentrationsUnited Kingdom
-
PepsiCo Global R&DCompletedMaximum Observed Plasma Glucose Concentration (Cmax)United States
-
Midwest Vein CenterUnknownPain During and After Endovenous Laser Obliteration of Large Saphenous Vein Based on Lidocaine Tumescent ConcentrationUnited States
-
Maco Productions S.A.S.SynteractHCRCompletedAdverse Effects in the Therapeutic Use of Plasma SubstitutesUnited Kingdom, Belgium, Greece, Spain
-
Astellas Pharma Global Development, Inc.Basilea Pharmaceutica International LtdCompletedHealthy Subjects | Pharmacokinetics of Isavuconazole | Pharmacokinetics of Plasma Mycophenolic Acid (MPA) | Pharmacokinetics of Plasma Phenolic Glucuronide of MPA (MPAG)United States
-
University College, LondonUnknownHypovolemia | Dehydration (Physiology) | Thirst; Due to Deprivation of Water | Plasma Osmolality IncreasedUnited Kingdom
-
Research & Diagnostic AntibodiesNational Institute of General Medical Sciences (NIGMS)Completed
-
OctapharmaCompletedAdverse Effects in the Therapeutic Use of Plasma SubstitutesUnited States
-
Centagen, Inc.CompletedQuality of Life | Stress | Blood Pressure | Joint Instability | Immune Deficiency | Lung Function Decreased | HDL Low | Energy Supply; Deficiency | Concentration Ability ImpairedUnited States
-
Oxford University Hospitals NHS TrustAmgenCompletedMyeloma | Smouldering Myeloma | Monoclonal Gammopathy of Undetermined Significance (MGUS)United Kingdom
-
Metabolic Technologies Inc.CompletedFocus of the Study is to Examine Plasma HMB Levels After Oral HMB SupplementationUnited States
-
Roswell Park Cancer InstituteCelgeneActive, not recruitingPlasma Cell Myeloma | Partial Response of Multiple Myeloma or Plasma Cell LeukemiaUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)Active, not recruiting
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingRefractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | Plasma Cell Leukemia | Loss of Chromosome 17p | Autologous Hematopoietic Stem Cell Transplant RecipientUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingMonoclonal Gammopathy of Undetermined Significance | Smoldering Plasma Cell MyelomaUnited States
-
Autolus LimitedEnrolling by invitationMultiple Myeloma | DLBCL | T Cell Lymphoma | Patients Followed for up to 15 Years Following Their First Dose of AUTO CAR T Cell Therapy | ALL, Adult and PediatricUnited Kingdom
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)TerminatedMultiple Myeloma and Plasma Cell Neoplasm | Precancerous ConditionUnited States
-
Ohio State University Comprehensive Cancer CenterRecruitingMultiple Myeloma | AL Amyloidosis | Monoclonal Gammopathy of Undetermined Significance | Plasma Cell DyscrasiasUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedWaldenstrom Macroglobulinemia | Refractory Plasma Cell Myeloma | Recurrent Adult Hodgkin Lymphoma | Recurrent Adult Non-Hodgkin Lymphoma | Recurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Refractory Non-Hodgkin Lymphoma | Recurrent Plasma Cell Myeloma | Plasma Cell Leukemia and other conditionsUnited States
-
Roswell Park Cancer InstituteCompletedPlasma Cell MyelomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingMonoclonal Gammopathy of Undetermined Significance | Plasma Cell MyelomaUnited States
-
University of PennsylvaniaCompletedIn Need of a Pap Smear (Cervical Cancer Screening) | In Need of a Blood Pressure Check (Hypertension Screening) | In Need of a Cholesterol Test (Lipid Disorder Screening) | In Need of a Fasting Plasma Glucose Test (Diabetes)United States
-
Gruppo Italiano Malattie EMatologiche dell'AdultoRecruitingMultiple MyelomaItaly, United Kingdom
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingIdasanutlin, Ixazomib Citrate, and Dexamethasone in Treating Patients With Relapsed Multiple MyelomaRecurrent Plasma Cell Myeloma | Loss of Chromosome 17pUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingMonoclonal Gammopathy of Undetermined Significance | Smoldering Plasma Cell MyelomaUnited States
-
Tufts Medical CenterCompletedPlasma Cell Dyscrasia | Monoclonal GammopathyUnited States
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)TerminatedLymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative Neoplasms | Unusual Cancers of ChildhoodUnited States
-
Janssen Research & Development, LLCCompletedMultiple Myeloma | Monoclonal Gammopathy of Undetermined Significance | Plasma Cell NeoplasmUnited States, Belgium, Russian Federation
-
UK Kidney AssociationRecruitingVasculitis | AL Amyloidosis | Tuberous Sclerosis | Fabry Disease | Cystinuria | Focal Segmental Glomerulosclerosis | IgA Nephropathy | Bartter Syndrome | Pure Red Cell Aplasia | Membranous Nephropathy | Atypical Hemolytic Uremic Syndrome | Autosomal Dominant Polycystic Kidney Disease | Cystinosis | Nephronophthisis | BK Nephropathy and other conditionsUnited Kingdom
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell Neoplasm | Psychosocial Effects of Cancer and Its Treatment | Myelodysplastic/Myeloproliferative Neoplasms | Therapy-related ToxicityUnited States
-
The Cleveland ClinicNational Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative Diseases | Psychosocial Effects of Cancer and Its TreatmentUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative Diseases | Psychosocial Effects of Cancer and Its TreatmentUnited States
-
Memorial Sloan Kettering Cancer CenterJanssen PharmaceuticalsRecruitingMultiple Myeloma | Monoclonal Gammopathy of Renal SignificanceUnited States
-
Yale UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedHypertriglyceridemia | Steatohepatitis | Non Alcoholic Fatty Liver Disease | Alanine Aminotransferase, Plasma Level of, Quantitative Trait Locus 1United States
-
Weill Medical College of Cornell UniversityMayo Clinic; Janssen Scientific Affairs, LLCTerminatedWaldenstrom Macroglobulinemia | Waldenstrom's Macroglobulinemia Recurrent | Waldenstrom's Macroglobulinemia Refractory | Waldenstrom's Disease | Waldenström; Hypergammaglobulinemia | Waldenstrom's Macroglobulinemia of Lymph Nodes | Waldenstrom's Macroglobulinaemia, Without Mention of RemissionUnited States
-
Virginia Commonwealth UniversityNovartis PharmaceuticalsCompletedPrior Acute Myocardial Infarction | Evidence of Systemic Inflammation (C Reactive Protein Plasma >2 mg/l) | Reduced Left Ventricle Ejection Fraction (<50%) | Symptoms of Heart Failure (NYHA Class II-III)United States
-
Celularity IncorporatedActive, not recruitingCardiovascular Diseases | Vascular Diseases | Neoplasms | Immune System Diseases | Neoplasms by Histologic Type | Lymphoproliferative Disorders | Immunoproliferative Disorders | Hematologic Diseases | Hemorrhagic Disorders | Multiple Myeloma | Paraproteinemias | Blood Protein Disorders | Antineoplastic Agents | Physiological... and other conditionsUnited States
-
Bristol-Myers SquibbCompleted
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedMultiple Myeloma | Plasma Cell Myeloma | Precancerous ConditionUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingMultiple Myeloma | Plasmacytoma | Plasmacytoma of BoneUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedPain | Lymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell Neoplasm | Precancerous Condition | Psychosocial Effects of Cancer and Its Treatment | Lymphoproliferative Disorder | Myelodysplastic/Myeloproliferative NeoplasmsUnited States
-
All4CureJanssen Scientific Affairs, LLCRecruitingMultiple Myeloma | Multiple Myeloma Without Mention of RemissionUnited States